- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1371
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1371 companies
Everest Medicines
Market Cap: HK$20.2b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$57.15
7D
-3.0%
1Y
127.7%
Amicus Therapeutics
Market Cap: US$2.6b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$8.32
7D
-1.9%
1Y
-22.4%
Veracyte
Market Cap: US$2.6b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$32.82
7D
-1.2%
1Y
-2.1%
Pfizer
Market Cap: ₹227.4b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,977.00
7D
-4.2%
1Y
-8.1%
Haw Par
Market Cap: S$3.2b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$14.44
7D
-0.1%
1Y
32.2%
Aspen Pharmacare Holdings
Market Cap: R42.3b
Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.
APN
R95.18
7D
-5.9%
1Y
-51.1%
Catalyst Pharmaceuticals
Market Cap: US$2.4b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$19.13
7D
-6.2%
1Y
-4.1%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥17.2b
Operates as contract development and manufacturing organization company in China and internationally.
603456
CN¥19.46
7D
-2.2%
1Y
44.5%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥17.1b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥10.57
7D
-3.6%
1Y
-19.9%
Zhejiang Jingxin Pharmaceutical
Market Cap: CN¥16.9b
Zhejiang Jingxin Pharmaceutical Co., Ltd.
002020
CN¥20.80
7D
2.9%
1Y
83.4%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 149.40
7D
-5.7%
1Y
-45.8%
Anhui Anke Biotechnology (Group)
Market Cap: CN¥16.8b
Anhui Anke Biotechnology (Group) Co., Ltd.
300009
CN¥10.09
7D
-5.8%
1Y
22.0%
ImmunityBio
Market Cap: US$2.4b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.46
7D
-13.7%
1Y
-36.9%
OneSource Specialty Pharma
Market Cap: ₹203.9b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally.
ONESOURCE
₹1,744.80
7D
-6.2%
1Y
n/a
Belite Bio
Market Cap: US$2.3b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.
BLTE
US$70.01
7D
-4.4%
1Y
49.4%
Celcuity
Market Cap: US$2.3b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$51.94
7D
-5.6%
1Y
264.7%
Hugel
Market Cap: ₩3.2t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩295,500.00
7D
-5.6%
1Y
18.4%
Shenzhen Hepalink Pharmaceutical Group
Market Cap: CN¥16.1b
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
002399
CN¥12.04
7D
-3.7%
1Y
20.0%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥16.1b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥8.28
7D
0.6%
1Y
6.8%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥15.8b
Engages in research, development, production, and sales of blood products in China.
000403
CN¥16.65
7D
-3.5%
1Y
-1.4%
Ocular Therapeutix
Market Cap: US$2.2b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$12.24
7D
-3.7%
1Y
39.4%
Travere Therapeutics
Market Cap: US$2.2b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$24.61
7D
1.7%
1Y
63.6%
Disc Medicine
Market Cap: US$2.2b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
IRON
US$62.50
7D
-0.2%
1Y
30.1%
Agios Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$36.61
7D
-3.5%
1Y
-23.8%
Galapagos
Market Cap: €1.8b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
GLPG
€27.90
7D
0.07%
1Y
6.8%
Mesoblast
Market Cap: AU$3.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.49
7D
6.0%
1Y
128.4%
Tibet Cheezheng Tibetan Medicine
Market Cap: CN¥14.9b
Tibet Cheezheng Tibetan Medicine Co., Ltd.
002287
CN¥26.10
7D
-3.5%
1Y
29.0%
CanSino Biologics
Market Cap: HK$16.2b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$48.90
7D
-7.0%
1Y
123.3%
Curaleaf Holdings
Market Cap: CA$2.9b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$3.54
7D
-2.2%
1Y
-13.7%
Arcutis Biotherapeutics
Market Cap: US$2.1b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$16.73
7D
-5.5%
1Y
82.6%
Genus
Market Cap: UK£1.5b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£23.20
7D
-6.3%
1Y
17.2%
Alembic Pharmaceuticals
Market Cap: ₹179.9b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹921.90
7D
-3.7%
1Y
-22.9%
Dermapharm Holding
Market Cap: €1.7b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMP
€32.10
7D
-1.8%
1Y
-8.0%
Shanghai Shyndec Pharmaceutical
Market Cap: CN¥14.3b
Shanghai Shyndec Pharmaceutical Co., Ltd.
600420
CN¥10.69
7D
-3.9%
1Y
-6.8%
Lotus Pharmaceutical
Market Cap: NT$61.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$232.00
7D
21.1%
1Y
-13.3%
Bonesupport Holding
Market Cap: SEK 18.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 287.60
7D
-5.7%
1Y
-7.2%